Antiretroviral Therapy for Control of the HIV-associated Tuberculosis Epidemic in Resource-Limited Settings

This publication has 63 references indexed in Scilit:

• Antiretroviral Drugs for Tuberculosis Control in the Era of HIV/AIDS
  Science, 2003
• Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study
  The Lancet, 2002
• Reduced Risk of Tuberculosis among Brazilian Patients with Advanced Human Immunodeficiency Virus Infection Treated with Highly Active Antiretroviral Therapy
  Clinical Infectious Diseases, 2002
• Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa
  AIDS, 2001
• HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group.
  2000
• Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial
  The Lancet, 2000
• Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection
  AIDS, 2000
• Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected Patients after the Introduction of Highly Active Antiretroviral Therapy
  American Journal of Respiratory and Critical Care Medicine, 2000
• AIDS-Related Opportunistic Illnesses Occurring After Initiation of Potent Antiretroviral Therapy
  JAMA, 1999
• Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.
  1999